Metabolic syndrome (MS) is a complex set of pathophysiological conditions characterized by abdominal obesity, insulin resistance, arterial hypertension, dyslipidemia, and disorders of carbohydrate metabolism. In recent years, the prevalence of MS has been sharply increasing both worldwide and among the population of Uzbekistan. The clinical importance of this condition lies in the fact that it is a strong independent risk factor for cardiovascular diseases, type 2 diabetes mellitus, atherosclerosis, and myocardial infarction.
Genetic predisposition, unhealthy diet, insufficient physical activity, stress, and hormonal imbalances play leading roles in the development of MS. Early detection and comprehensive preventive strategies are essential for reducing the burden of cardiovascular diseases.

abdominal obesity, cardiovascular diseases, atherosclerosis, diabetes mellitus.

Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the IDF, AHA/NHLBI, WHF, IAS, and IASO. Circulation. 2009;120(16):1640–1645.

International Diabetes Federation. IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF; 2006.

Grundy S.M., Brewer H.B., Cleeman J.I., et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/AHA. Circulation. 2004;109:433–438.

WHO Consultation. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894. Geneva: WHO; 2000.

Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease. Medical Clinics of North America. 2011;95(5):875–892.

Kassi E., Pervanidou P., Kaltsas G., Chrousos G. Metabolic syndrome: definitions and controversies. BMC Medicine. 2011;9:48.

Saklayen M.G. The global epidemic of metabolic syndrome. Current Hypertension Reports. 2018;20(2):12.

Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet. 2005;365(9468):1415–1428.

Lim S., Meigs J.B. Epidemiology of metabolic syndrome in Korea and other Asian countries. Korean Journal of Internal Medicine. 2022;37(1):1–13.

DeFronzo R.A., Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–194.

Mahalle N., Nagmane A., Naik S., et al. Association of metabolic syndrome with inflammation and endothelial dysfunction in Indian adults. Indian Journal of Endocrinology and Metabolism. 2012;16(4):617–623.